Nivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.

Basit Öğe Kaydı
dc.authoridErturk, Ismail/0000-0001-6835-0988
dc.authoridYekedüz, Emre/0000-0001-6819-5930
dc.authoridKilickap, Saadettin/0000-0003-1637-7390
dc.authoridÖksüzoğlu Çakmak, Ömür Berna/0000-0002-2756-8646
dc.authoridUcar, Gokhan/0000-0002-7649-1075
dc.authoridMUSTAFA, ÖZGÜROĞLU/0000-0002-8417-8628;
dc.authorwosidErturk, Ismail/B-4317-2019
dc.authorwosidYekedüz, Emre/ABA-5814-2020
dc.authorwosidKilickap, Saadettin/AAP-3732-2021
dc.authorwosidÖksüzoğlu Çakmak, Ömür Berna/HKN-6428-2023
dc.authorwosidArslan, Cagatay/I-1932-2016
dc.authorwosidUcar, Gokhan/AAA-8198-2021
dc.authorwosidMUSTAFA, ÖZGÜROĞLU/A-8234-2016
dc.contributor.authorYekeduz, Emre
dc.contributor.authorErturk, Ismail
dc.contributor.authorTural, Deniz
dc.contributor.authorKaradurmus, Nuri
dc.contributor.authorKarakaya, Serdar
dc.contributor.authorHizal, Mutlu
dc.contributor.authorArslan, Cagatay
dc.date.accessioned2024-06-12T11:22:28Z
dc.date.available2024-06-12T11:22:28Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.descriptionASCO Genitourinary Cancers Symposium (GU ASCO) -- FEB 11-13, 2021 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipASCOen_US
dc.identifier.doi10.1200/JCO.2021.39.6_suppl.321
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue6en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2021.39.6_suppl.321
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25944
dc.identifier.volume39en_US
dc.identifier.wosWOS:000636801500336en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleNivolumab as second-line treatment and beyond for metastatic renal cell carcinoma: A real-life experience from Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu